Monopar Therapeutics Inc.

MNPRNASDAQHealthcareBiotechnology

$69.27- (-)1Y −10.40%

As of Oct 16, 2026 close

Market cap: $613.35M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $50.07$124.82
Volume (live): -
Avg. volume (3M): 151.35K

Monopar Therapeutics Inc. (MNPR) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Monopar Therapeutics Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy

Based on 7 unique analysts

(8 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$129.29

+86.65% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest MNPR Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Sep 28, 2026	Biren Amin	Piper Sandler	Maintains	Buy	$101.00 → $123.00 +22.00 (+21.8%)
Sep 22, 2026	Andres Y. Maldonado	HC Wainwright	Maintains	Buy	$125.00
Sep 11, 2026	Etzer Darout	Barclays	Maintains	Buy	$128.00 → $145.00 +17.00 (+13.3%)
Aug 17, 2026	Maxwell Skor	Morgan Stanley	Reiterates	Buy	$115.00 → $130.00 +15.00 (+13.0%)
Aug 13, 2026	Kristen Kluska	Cantor Fitzgerald	Downgrades	Hold	$109.00 → $119.00 +10.00 (+9.2%)
Aug 12, 2026	Boris Peaker	JonesTrading	Maintains	Buy	$130.00
Aug 12, 2026	Kristen Kluska	Cantor Fitzgerald	Upgrades	Hold	$109.00 → $119.00 +10.00 (+9.2%)
Aug 12, 2026	Jeet Mukherjee	BTIG	Maintains	Buy	$117.00 → $133.00 +16.00 (+13.7%)

Biren Amin

Piper Sandler

BuyMaintains

$101.00 → $123.00

Sep 28

Andres Y. Maldonado

HC Wainwright

BuyMaintains

$125.00

Sep 22

Etzer Darout

Barclays

BuyMaintains

$128.00 → $145.00

Sep 11

Maxwell Skor

Morgan Stanley

BuyReiterates

$115.00 → $130.00

Aug 17

Kristen Kluska

Cantor Fitzgerald

HoldDowngrades

$109.00 → $119.00

Aug 13

Boris Peaker

JonesTrading

BuyMaintains

$130.00

Aug 12

Kristen Kluska

Cantor Fitzgerald

HoldUpgrades

$109.00 → $119.00

Aug 12

Jeet Mukherjee

BTIG

BuyMaintains

$117.00 → $133.00

Aug 12

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 28, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for MNPR?

The analyst consensus rating for MNPR is Buy, based on the latest ratings from 7 analysts over the last 90 days.

What is the average price target for MNPR?

The average 12-month price target for MNPR is $129.29, representing an upside of 86.6% from the Oct 16, 2026 close of $69.27.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.